日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Independent Testing of Published CT Models for PD-L1 Status in Non-Small Cell Lung Cancer

对已发表的用于检测非小细胞肺癌中PD-L1状态的CT模型进行独立测试

O'Shea, Robert; Horst, Carolyn; Manickavasagar, Thubeena; Josephides, Eleni; Hunter, Sarah; Taniere, Phillipe; Nonaka, Daisuke; Van Hemelrijck, Mieke; Spicer, James; Hughes, Daniel J; Cook, Gary J R; Bille, Andrea; Karapanagiotou, Eleni; Goh, Vicky

Neoadjuvant chemoimmunotherapy in non-small cell lung cancer: evolving resectability criteria, biomarker-driven postoperative management, and emerging therapeutic strategies

非小细胞肺癌新辅助化疗免疫疗法:不断变化的切除标准、生物标志物驱动的术后管理和新兴治疗策略

Patel, Akshay; Wakeam, Elliot; Josephides, Eleni; Lampridis, Savvas; Karapanagiotou, Eleni; Middleton, Gary; Naidu, Babu; De Perrot, Marc; Bille, Andrea

Unravelling single-cell DNA replication timing dynamics using machine learning reveals heterogeneity in cancer progression

利用机器学习揭示单细胞DNA复制时间动态,揭示癌症进展的异质性

Josephides, Joseph M; Chen, Chun-Long

Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry

基于Transformer的AI方法揭示晚期非小细胞肺癌(NSCLC)且PD-L1表达≥50%患者的长期、时间依赖性预后复杂性:来自帕博利珠单抗5年全球注册研究的启示

Cortellini, Alessio; Santo, Valentina; Brunetti, Leonardo; Garbo, Edoardo; Pinato, David J; La Cava, Giulia; Naidoo, Jarushka; Katz, Artur; Loza, Monica; Neal, Joel W; Genova, Carlo; Gettinger, Scott; Kim, So Yeon; Jayakrishnan, Ritujith; El Zarif, Talal; Russano, Marco; Pecci, Federica; Di Federico, Alessandro; Alessi, Joao V; Montrone, Michele; Owen, Dwight H; Ramella, Sara; Signorelli, Diego; Fidler, Mary Jo; Li, Mingjia; Camerini, Andrea; Halmos, Balazs; Vincenzi, Bruno; Metro, Giulio; Passiglia, Francesco; Yendamuri, Sai; Guida, Annalisa; Ghidini, Michele; D'Alessio, Antonio; Banna, Giuseppe L; Fulgenzi, Claudia A M; Grisanti, Salvatore; Grossi, Francesco; D'Incecco, Armida; Josephides, Eleni; Van Hemelrijck, Mieke; Russo, Alessandro; Gelibter, Alain; Spinelli, Gianpaolo; Verrico, Monica; Tomasik, Bartłomiej; Giusti, Raffaele; Balachandran, Kirsty; Bria, Emilio; Sebastian, Martin; Rost, Maximilian; Forster, Martin; Mukherjee, Uma; Landi, Lorenza; Mazzoni, Francesca; Aujayeb, Avinash; Dupont, Manuel; Curioni-Fontecedro, Alessandra; Chiari, Rita; Sforza, Vincenzo; Tiseo, Marcello; Friedlaender, Alex; Addeo, Alfredo; Zoratto, Federica; De Tursi, Michele; Cantini, Luca; Roca, Elisa; Mountzios, Giannis; Rocco, Danilo; Della Gravara, Luigi; Kalvapudi, Sukumar; Inno, Alessandro; Bironzo, Paolo; Di Marco Barros, Rafael; O'Reilly, David; Fitzpatrick, Orla; Karapanagiotou, Eleni; Monnet, Isabelle; Baena, Javier; Macerelli, Marianna; Piedra, Aida; Agustoni, Francesco; Cortinovis, Diego Luigi; Tonini, Giuseppe; Minuti, Gabriele; Bennati, Chiara; Mezquita, Laura; Gorría, Teresa; Servetto, Alberto; Beninato, Teresa; Lo Russo, Giuseppe; Prelaj, Arsela; De Giglio, Andrea; Rogado, Jacobo; Moliner, Laura; Nadal, Ernest; Biello, Federica; Nana, Frank Aboubakar; Dingemans, Anne-Marie; Aerts, Joachim G J V; Ferrara, Roberto; Abu Hejleh, Taher; Takada, Kazuki; Naqash, Abdul Rafeh; Garassino, Marina Chiara; Peters, Solange; Wakelee, Heather A; Nassar, Amin H; Ricciuti, Biagio; Soda, Paolo; Caruso, Camillo Maria; Guarrasi, Valerio

Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry

在临床试验之外,接受一线帕博利珠单抗治疗的PD-L1≥50%晚期非小细胞肺癌患者的5年生存率决定因素:来自Pembro-real 5Y全球注册研究的结果

Cortellini, Alessio; Brunetti, Leonardo; Di Fazio, Giuseppina Rita; Garbo, Edoardo; Pinato, David J; Naidoo, Jarushka; Katz, Artur; Loza, Monica; Neal, Joel W; Genova, Carlo; Gettinger, Scott; Kim, So Yeon; Jayakrishnan, Ritujith; El Zarif, Talal; Russano, Marco; Pecci, Federica; Di Federico, Alessandro; Awad, Mark; Alessi, Joao V; Montrone, Michele; Owen, Dwight Hall; Signorelli, Diego; Fidler, Mary Jo; Li, Mingjia; Camerini, Andrea; De Giglio, Andrea; Young, Lauren; Vincenzi, Bruno; Metro, Giulio; Passiglia, Francesco; Yendamuri, Sai; Guida, Annalisa; Ghidini, Michele; Awosika, Nichola O; Napolitano, Andrea; Fulgenzi, Claudia A M; Grisanti, Salvatore; Grossi, Francesco; D'Incecco, Armida; Josephides, Eleni; Van Hemelrijck, Mieke; Russo, Alessandro; Gelibter, Alain; Spinelli, Gianpaolo; Verrico, Monica; Tomasik, Bartłomiej; Giusti, Raffaele; Newsom-Davis, Thomas; Bria, Emilio; Sebastian, Martin; Rost, Maximilian; Forster, Martin; Mukherjee, Uma; Landi, Lorenza; Mazzoni, Francesca; Aujayeb, Avinash; Dupont, Manuel; Curioni-Fontecedro, Alessandra; Chiari, Rita; Pantano, Francesco; Morabito, Alessandro; Leonetti, Alessandro; Friedlaender, Alex; Addeo, Alfredo; Zoratto, Federica; De Tursi, Michele; Cantini, Luca; Roca, Elisa; Mountzios, Giannis; Della Gravara, Luigi; Kalvapudi, Sukumar; Inno, Alessandro; Bironzo, Paolo; Di Marco Barros, Rafael; O'Reilly, David; Bell, Jack; Karapanagiotou, Eleni; Monnet, Isabelle; Baena, Javier; Macerelli, Marianna; Majem, Margarita; Agustoni, Francesco; Cortinovis, Diego Luigi; Tonini, Giuseppe; Minuti, Gabriele; Bennati, Chiara; Mezquita, Laura; Gorría, Teresa; Servetto, Alberto; Beninato, Teresa; Lo Russo, Giuseppe; Rogado, Jacobo; Moliner, Laura; Biello, Federica; Aboubakar Nana, Frank; Dingemans, Anne-Marie; Aerts, Joachim G J V; Ferrara, Roberto; Torri, Valter; Hejleh, Taher Abu; Takada, Kazuki; Naqash, Abdul Rafeh; Garassino, Marina; Peters, Solange; Wakelee, Heather; Nassar, Amin H; Ricciuti, Biagio

Predictors and Outcomes of Non-Small Cell Lung Carcinoma Patients Following Severe Immune Checkpoint Inhibitor Toxicity: A Real-World UK Multi-Centre Study

非小细胞肺癌患者发生严重免疫检查点抑制剂毒性后的预测因素和预后:一项英国多中心真实世界研究

Mahmood, Umair; Josephides, Eleni; Chitnis, Meenali; Skwarski, Michael; Gennatas, Spyridon; Ghosh, Sharmistha; Spicer, James; Karapanagiotou, Eleni; Ahmad, Tanya; Forster, Martin; Jamal-Hanjani, Mariam; Benafif, Sarah; Swanton, Charles; Lee, Siow-Ming; Papadatos-Pastos, Dionysis; Georgiou, Alexandros; Coupe, Nicholas

Outcomes Following Radiotherapy for Oligoprogressive NSCLC on Immune Checkpoint Inhibitors: A Real-World, Multinational Experience

免疫检查点抑制剂治疗寡转移进展型非小细胞肺癌后放疗的疗效:一项真实世界、多国经验

Mahmood, Umair; Josephides, Eleni; Coupe, Nicholas; Smith, Daniel; Ahmad, Shahreen; Al-Salihi, Omar; Mak, Sze M; Chitnis, Meenali; Georgiou, Alexandros; Ajzensztejn, Daniel; Karapanagiotou, Eleni; Higgins, Geoff S; Panakis, Niki; Schoenfeld, Jonathan D; Skwarski, Michael

Advanced thymic epithelial tumour resection: vascular resection and reconstruction strategy

晚期胸腺上皮肿瘤切除术:血管切除和重建策略

Patel, Akshay J; Josephides, Eleni; Bilkhu, Rajdeep; Bosco, Paolo; Lucchese, Gianluca; Bille, Andrea

Guy's Cancer Cohort: Guy's Cancer Centre's Real-World Evidence Programme 5 years later

盖伊癌症队列:盖伊癌症中心真实世界证据项目五年后

Moss, C L; Russell, B; George, G; Handford, J; Josephides, E; Green, S; Mera, A; Haire, K; Igra, A; Gladman, M; Hachlili, S; Davies, A; Smith, D; Dolly, S; Ross, P; Lei, M; Sawyer, E; Harrison, C; Kazmi, M; Rigg, A; Van Hemelrijck, M

Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([(18)F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancer

利用氟-18氟代脱氧葡萄糖([(18)F]FDG)正电子发射断层扫描/计算机断层扫描(PET/CT)代谢参数预测可切除非小细胞肺癌中程序性死亡配体1(PD-L1)的表达

Hughes, Daniel Johnathan; Josephides, Eleni; O'Shea, Robert; Manickavasagar, Thubeena; Horst, Carolyn; Hunter, Sarah; Tanière, Philippe; Nonaka, Daisuke; Van Hemelrijck, Mieke; Spicer, James; Goh, Vicky; Bille, Andrea; Karapanagiotou, Eleni; Cook, Gary J R